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Reducing the stress of drug 
administration: implications for 
the 3Rs
Sarah A. Stuart & Emma S.J. Robinson
Restraint in animals is known to cause stress but is used during almost all scientific procedures in 
rodents, representing a major welfare and scientific issue. Administration of substances, a key part 
of most scientific procedures, almost always involves physical restraint of the animal. In this study, 
we developed a method to inject substances to rats using a non-restrained technique. We then 
compared the physiological, behavioral and emotional impacts of restrained versus non-restrained 
injection procedures. Our results highlight the negative welfare implications associated with physical 
restraint and demonstrate a method which can be used to avoid this. Our work shows how adopting 
strategies that avoid restraint can minimize a widespread source of stress in laboratory animals and 
improve welfare through refinement.
The 3Rs (Reduce, Refine and Replace) are an important consideration for all scientific experiments 
involving animals1. They underpin the legislation in most countries where nationwide laws regulate the 
use of animals in scientific procedures as well as forming the foundation of institutional and publication 
guidelines2. Whilst major steps have been made in terms of the development of alternative methods to 
replace the use of animals and reduce the numbers of procedures undertaken, further improvements 
in animal welfare can be made through refinement of procedures3,4. One particular aspect of animal 
research that could benefit from refinement is the impact of restraint stress induced by substance admin-
istration techniques5–7. Stress, particularly associated which physical restraint, has been shown to cause a 
negative affective state in animals, as well as cardiovascular and hormonal changes8–11. Taking measures 
to minimise this source of stress will enhance animal welfare and could improve the variability and 
reproducibility of scientific data in the fields of pharmacology, toxicology and drug safety, leading to a 
reduction in the numbers of animals needed.
The majority of preclinical studies involve the administration of substances, and in rodents one of 
the most widely used routes of administration is intraperitoneal (IP). Conventional approaches for sub-
stance administration in rodents (IP, subcutaneous, gastric gavage), specified in standardized protocols, 
involve restraining the animal either using a firm grip around the neck and shoulder or by using a 
scruffing technique12 (Fig.  1a–c, also see http://www.jove.com/video/2771/manual-restraint-comm
on-compound-administration-routes-mice and http://www.ahwla.org.uk/index.html; http://www.proce-
dureswithcare.org.uk for published online guides). For rats, particularly larger animals, most guidelines 
recommend that the procedure is done by two people: one to restrain the animal and the other to carry 
out the injection13 (Fig.  1a) (see http://www.procedureswithcare.org.uk). Studies into the effects of IP 
administration and repeated experience of the technique suggest the procedure is stressful and animals 
show sensitization rather than habituation over repeated injections5,14. Restraint stress in animals is also 
a commonly used method of inducing a negative affective state and repeated restraint stress is used as a 
chronic stress procedure to induce a depression-like phenotype in rats15–17.
We have undertaken a study to investigate the impact of restraint on animal welfare. We hypothesized 
that the physical restraint used during IP substance administration is the major source of stress and 
aversion to the technique, rather than the injection itself. To test this hypothesis we compared effects 
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on behavioral and physiological indicators of stress during IP injection using a conventional restraint 
method (Fig.  1c) and a novel method of handling involving minimal restraint to the animal (Fig.  1d, 
supplementary movie 1). We also utilized a new assay we developed in our laboratory to study affective 
states in rats, the affective bias test (ABT)17. This assay provides an objective measure of the effects of 
manipulations on an animal’s emotional state and therefore adds another dimension to our analysis of 
the welfare implications of restraint in rodents.
Results
To assess stress-related behavior during IP substance administration, measurements of vocalization, 
escape behavior (struggling), and defecation were made by an independent observer. Since the strain18 
and prior handling of the animal6,19 can underlie differences in stress responsiveness, we assessed male 
rats from different strains, ages and handling status, including well-handled Lister Hooded (n = 8), 
unhandled stock Wistar (n = 5), unhandled young Wistar (n = 6), unhandled ex-stud Wistar (n = 5), 
and unhandled young Sprague Dawley rats (n = 4). IP injections were made using saline in a 1ml/kg 
dose volume or, in the young, unhandled Wistar rats (n = 6), 3 mg/kg amphetamine in 1ml/kg saline, 
using one of the two methods. For the animals dosed with amphetamine, their behavior was scored as 
described above but 15 mins after injection, animals were killed and blood samples were collected and 
processed for corticosterone levels and plasma amphetamine.
The results from the behavioral observations revealed a main effect for struggling (Kruskal-Wallis, 
H9 = 25.5, p = 0.0025, n = 4–8 per group, Fig.  2a), vocalization (Kruskal-Wallis, H9 = 27.3, p = 0.0012, 
n = 4–8 per group, Fig.  2b) and fecal count (Kruskal-Wallis, H9 = 18.7, p = 0.028, n = 4–8 per group, 
Fig. 2c). Post-hoc pairwise comparisons also revealed a significant difference between dosing methods 
for the Lister-hooded rat strain for struggling scores and vocalization. As the individual group numbers 
were relatively small and each subgroup was fully counter-balanced, results for all animals were pooled 
for each method. The resulting grouped data showed that the modified dosing method was associated 
with a reduction in struggling (Mann-Whitney U test, U26 = 146.0, p < 0.0001, n = 28 per group, Fig. 2a), 
vocalization scores (Mann-Whitney U test, U2 = 119.5, p < 0.001, n = 28 per group, Fig.  2b). and fecal 
count (Mann-Whitney U test, U26 = 272.5, p = 0.01, n = 28 per group, Fig.  2c). These findings suggest 
that overt behaviors associated with aversion and stress are reduced in animals when handled for IP 
injection using our modified method. Perhaps most importantly, we also found that the modified method 
could be used across a range of different subgroups of animals including larger animals (> 500 g) and 
animals that had received minimal prior handling.
In addition to the observational data, the results from the analysis of corticosterone levels showed 
that the modified method is associated with lower levels of this stress hormone (unpaired t-test: t9 = 5.74, 
p = 0.0003, n = 5–6 per group; Fig.  2d). Analysis of the plasma samples from the same animals also 
revealed no significant difference in levels of amphetamine between the groups (unpaired t-test: t9 = 0.43, 
p = 0.68, n = 5–6 per group, Fig. 2e).
In a separate cohort consisting of male Lister Hooded rats (n = 16), the rodent ABT was used to test 
if the restrained dosing method induced a more negative affective state relative to the modified method. 
These studies were all carried out by a second handler to confirm that the method was transferable 
between researchers. The assay was carried out as previously described17, with two independent learning 
experiences (finding a food reward in a specific digging substrate) encountered following IP dosing. 
One experience was learned following administration of saline (1ml/kg) using the conventional scruff 
method, and the other was learned following use of the modified technique. A preference test was then 
used to assess cognitive affective bias. The ABT has previously been used to quantify negative affective 
bias associated with both pharmacological and psychosocial stressors17. Using the ABT we showed that 
the conventional method of IP substance administration induces a negative affective state relative to the 
modified technique, resulting in an overall negative affective bias (one sample t-test: t14 = 2.48, p = 0.03, 
n = 15; Fig. 2f).
Figure 1. Demonstration of handling techniques for intraperitoneal dosing. (a) two-person restraint 
method, (b) one-person restraint, (c) scruff, (d) modified method. Also see online supplementary movie.
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Discussion
In this study we demonstrated and validated a new technique to minimise the use of physical restraint 
during administration of substances to rats by injection. These data also provide a quantitative analysis 
of the negative welfare implications of using restraint during substance administration and how this can 
be avoided. Animals handled using our modified technique were in a more positive affective state and 
showed lower stress hormone levels and aversive behaviors. Importantly, the bioavailability of the drug 
was not altered by the modified technique. Our findings show that although restraint is an accepted 
and often thought of as unavoidable part of undertaking procedures in rodents, it is not necessary and 
alternative, refined methods are achievable. In developing this refined method our studies also dissociate 
between the effects of discomfort from the injection and the stress associated with physical restraint.
In our study, animals showed lower levels of overt behaviours including reduced vocalization, strug-
gling and defecation when dosed IP using the modified method. In the well-handled Lister Hooded 
rats almost no overt behaviours were recorded suggesting that prior habituation to handling can further 
enhance the benefits of this methodological adaption. These data suggest that the injection procedure 
itself is associated with little or no aversion (particularly in well-handled animals) and that the major 
stressor is the restraint used to administer the injection. It should be noted that neither method included 
tilting the animal so its head was lower than its abdomen as suggested in some guidance notes. Although 
tilting is purported to shift the viscera away from the injection site20, this manipulation has been called 
into question as the slight vacuum in the abdomen prevents the viscera from moving20,21. Tilting the 
animal is also likely to add to the aversive nature of the procedure and is not feasible with the modified 
method. Data from the analysis of plasma levels of amphetamine following either method were not 
significantly different suggesting that the modification to the dosing procedure did not adversely affect 
bioavailability.
The outcomes of the ABT provide an objective measure of the affective state of the animals and sug-
gest that removing restraint from the drug administration procedure benefits the animal’s welfare. The 
negative bias towards the experience learned following injection using the restrained method suggests 
animals are in a more positive affective state when the modified method is used. Understanding the 
affective state of an animal during common laboratory procedures is a valuable way of assessing the 
impact of the manipulation on welfare, but until recently it has not been easily achieved22. Much of how 
Figure 2. Effect of IP dosing using the conventional scruff method (C) versus the modified method (M) 
on behavioural, physiological and psychological measures of stress. Results for (a) struggling,  
(b) vocalization and (c) fecal counts during dosing in LH = Lister hooded, 400–550 g, n = 8 per group, 
young Wistar, 280-320g, n = 6 per group, Stock Wistar 400-500 g, n = 5 per group, Stud Wistar 550–700 g, 
n = 5 per group, and Sprague Dawley rats 290–320 g, n = 4 per group, All, n = 24 per group. Data shown 
as mean ± s.e.m. Plasma analysis of (d) corticosterone and (e) amphetamine for conventional (n = 6) and 
modified methods (n = 5; insufficient blood was collected from one animal to process). Data shown as 
mean ± s.e.m. (f) Affective bias induced by intraperitoneal dosing by the conventional versus the modified 
method as assessed in the ABT. Each data point represents an individual rat. Error bar, s.e.m., n = 15 rats. 
*p < 0.05, **p < 0.01, ***p < 0.001.
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we view the impact of procedures on animal welfare is based on observational analysis and some degree 
of anthropomorphism of what we, as humans, think is best for the animal. Within this context, the wide-
spread use of restraint and lack of consideration of the impact this may have on experimental outcomes 
suggests that most researchers consider that this has minimal impact on the animal. Our results provide 
objective evidence that removing restraint from the method used to administer a substance is associated 
with animals being in a more positive affective state, and it therefore represents a major welfare advance. 
This work supports other studies in rats showing how alternative handling techniques, such as playful 
tickling, may reduce stress associated with routine injections23, as well as work in mice that demonstrates 
the beneficial effects of a more appropriate choice of handling method on animal welfare18.
The impact of stress on the experimental outcomes is not often discussed and yet is likely to contrib-
ute to both the primary measure in an experiment and the variability and reproducibility of the data, an 
area receiving much discussion in the recent literature24. This is particularly the case for studies involving 
behavioral outcomes although it is also likely to impact on other measures including ex vivo studies. 
Release of stress hormones will alter the animal’s physiological, neurochemical and psychological state 
as well as it’s response to drug treatments. Studies using restraint stress as an experimental manipulation, 
have found effects in a wide range of behavioural paradigms including drug self-administration25, learn-
ing and memory26, pain responses27 and food and water intake28. Although the period of restraint stress 
used during administration of substances is much shorter in duration than most experimental manip-
ulations, the results from our corticosterone data show that even this short period of physical restraint 
increases stress hormones by approximately 50% above that of animals handled and injected without 
restraint (Fig. 2d). There are also examples of endogenous and exogenous substances exhibiting inverted 
U-shaped dose response relationships meaning that baseline levels of stress and arousal can dramatically 
alter the outcomes of the test manipulation29. Removing a major stress-inducing factor such as restraint 
could therefore benefit the experimental outcomes as well as welfare.
In the context of parenteral substance administration in rats, we have shown that refined methods 
which involve minimal restraint are achievable and confirm the welfare benefits that this can achieve. 
Our method allows for substances to be injected with minimal stress effects on the animal. The work also 
highlights the wider welfare implications of restraining rodents during handling and dosing procedures. 
Future strategies are needed to address the use of restraint within animal research and improve under-
standing of the implications of the associated stress on scientific data and animal welfare.
Methods
Animals and dosing procedures. For the behavioral and physiological analysis, 5 groups of rats 
were tested: well-handled male Lister Hooded (Harlan, UK, 400–550 g, n = 8 per group), young male 
Wistar (Charles River, UK, 280–320 g, n = 6 per group), unhandled stock male Wistar (Charles River, 
UK, 400–500 g, n = 5 per group), unhandled stud Wistar (Charles River, UK, 550–700 g, n = 5 per group) 
and unhandled young Sprague Dawley rats (Charles River, UK, 290–320 g, n = 4 per group). Half the 
animals from each group were injected intraperitoneally (IP) using a conventional restrained method 
(Fig.  1c) and the other half were dosed using our modified method (Fig.  1d, also see online movie). 
Injections consisted of 1ml/kg saline for all groups except the young male Wistar which received 3mg/
kg amphetamine (Sigma Aldrich, UK) in 1ml/kg 0.9% saline. ‘Unhandled’ refers to animals that have 
undergone handling for routine cage cleaning but no other habituation to human contact. ‘Well-handled’ 
refers to animals which had been used in behavioural studies and received regular handling including 
IP dosing using the modified method. Animals used for the ABT were a separate cohort of male Lister 
Hooded rats (Harlan, UK, 400–500 g, n = 16). All procedures were approved by the Home Office UK 
and conducted in accordance with the requirements of the UK Animals (Scientific Procedures) Act 1986.
Behavioral observations. Behavioral observations of struggling, vocalizations and fecal counts were 
made by an independent observer. The observer scored each animal for struggling behaviour (scale 
0–10, 0 = no struggling, 5 = some attempts to escape restraint during procedure, 10 = animal moving a 
lot and trying to escape restraint throughout procedure), vocalization (0 = no vocalization, 3 = audible 
vocalization for some of the procedure, 5 = audible vocalization throughout procedure) and fecal count 
(number of faecal pellets eliminated from start to end of the procedure).
Plasma analysis. Animals were killed by stunning and cervical dislocation 15 min after drug admin-
istration. Immediately following cervical dislocation the animals were decapitated and the trunk blood 
collected into Eppendorf tubes containing 0.5M EDTA (Sigma Aldrich, UK). Samples were immediately 
placed on ice and then centrifuged at 4000 rpm for 10 mins to pellet cells, with plasma supernatant 
removed and stored at − 20 °C until analysis.
Analysis of plasma corticosterone concentrations was carried out by Christian Wood and Yvonne 
Kershaw using radioimmunoassay. Primary rabbit anti-rat corticosterone antibody (supplied by Gábor 
Makara, Institute of Experimental Medicine, Budapest, Hungary) and [125I]-corticosterone tracer (Institute 
of Isotopes, Hungary) were provided by Dr Becky Conway-Campbell and Professor Stafford Lightman 
(School of Clinical Sciences, University of Bristol). The specific activity of the tracer was 10uCi/ml.
For the assay, a corticosterone standard curve was created using 1:2 serial dilutions of a 100ng/ml of 
corticosterone (Sigma-Aldrich, UK) in citrate buffer in addition to two quality controls (QCs) of 100ng/ml 
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and 20ng/ml corticosterone. Each 10ul plasma sample was diluted to 500ul in citrate buffer (25mM 
tri-sodium citrate, 50mM sodium dihydrogen orthophosphate, 1g/l BSA (Sigma-Aldrich, UK)) to dena-
ture corticosterone-binding globulins. All standards, QCs and samples were processed in 100ul tripli-
cate aliquots and were incubated at 4°C overnight containing 50ul of primary antibody (20mg antibody 
dissolved in 0.2ml dH2O, 9.8ml 0.9% saline, 500ml citrate buffer) and tracer. Following this, all samples 
were mixed with a dextran/charcoal T70 solution (0.05 g Dextran T70 (Pharmacia Biotech, Sweden) 
and 0.5 g activated charcoal (Sigma-Aldrich, UK)) and centrifuged for 15 minutes at 4000 rpm (4 °C). 
The supernatant for each sample was then aspirated and loaded onto a gamma counter (E5010 Cobra II 
Auto Gamma, Perkin Elmer, Netherlands). The assay had a limit of detection of 1ng/ml. The intra- and 
inter-assay coefficients of variation of the corticosterone assay were 16.7 and 13.3%, respectively.
Plasma amphetamine analysis. Analysis of the levels of amphetamine in individual plasma samples 
was carried out by Ian Cummins, University of Durham. Amphetamine content was determined by gas 
chromatography-mass spectrometry (GC-MS) following isolation by solid-phase extraction (SPE) and 
derivatisation with heptafluorobutyric anhydride (HFBA), using published, validated protocols30,31 (also 
see Varian Certify Methods Manual, http://www.crawfordscientific.com/downloads/Application-Notes/
Certify_Methods_Manual.pdf ).
The method was checked for linearity, limit of detection and recovery using a supplied standard of 
amphetamine sulphate and control serum. Accuracy of injection was validated by injection of triplicate 
standards over a range of concentrations, giving an RSD of 2%. Single ion monitoring (SIM) of char-
acteristic fragment ions was used to quantify amphetamine and the SIM data for m/z 118 and m/z 240 
were combined.
Affective bias test training and testing procedure. The animals were trained and tested in a 
Perspex arena, 40 cm2. The substrates e.g. bedding, sawdust, sand, cloth, perlite etc., were placed in glazed 
pottery bowls (5 inch) and presented in a pseudo-random spatial order to prevent rats using spatial cues 
to select the correct substrate.
Training. The rats were habituated to the test arena and trained to dig in two bowls filled with sawdust 
to obtain a quantity of food pellets (45mg rodent tablet, TestDiet). Training was complete once each rat 
was able to find the pellet in each bowl on 12 consecutive trials within 5 minutes.
General ABT Protocol. The study followed a standard protocol of four pairing sessions followed by a 
preference test session on the fifth day. Rats were randomly assigned to one of four counterbalanced 
groups to prevent bias associated with substrate, treatment, or treatment day. Each pairing session con-
sisted of individual trials in which the rat was required to choose between one of the two bowls to locate 
a food pellet reward. In each of these trials, one of the bowls contained a ‘reward-paired’ substrate (A) 
and the other contained a different, ‘blank’ substrate (C). The blank substrate was the same for all four 
pairing sessions. In the blank substrate, the equivalent number of food pellets was crushed into the bowl 
to avoid discrimination from the reward-paired substrate based on odour. The rat was placed in front of 
the two bowls and allowed to dig in one of the two bowls. Once the animal began to dig, the other bowl 
was removed from the test arena. Digging in the reward-paired substrate was recorded as a correct trial, 
and digging in the blank substrate was recorded as an incorrect trial. The latency to dig was also recorded 
for each trial and the session was completed once the rat reached a criterion of 6 consecutive correct 
trials (probability of by chance being 0.015). The second pairing session followed the same protocol, but 
the rats were presented with the second reward-paired substrate (B). The pairing sessions were repeated 
to give a total of four sessions on consecutive days. On the fifth day, the rats were presented with both 
reward-paired substrates for a total of 30 trials. A single pellet reward was placed in one of the bowls 
using a random reinforcement protocol such that there was a 1 in 3 reward probability for each substrate. 
The random reinforcement schedule was used to maintain animals responding during the preference test 
but reduce the potential confounds associated with new learning.
Restraint-induced stress. For each rat, one substrate (A or B) was paired immediately following dosing 
with saline using the conventional scruff method (Fig. 1c), and the other was paired following use of the 
modified technique (Fig. 1d).
Statistical Analysis
All data were analysed using GraphPad Prism (Version 5). Results from the behavioural observations 
were analysed using a one way ANOVA, non-parametric Kruskal-Wallis test. Planned pairwise com-
parisons for each sub-group and method were made using a Mann-Whitney U tests. In addition, data 
for each method was pooled for the different sub-groups tested and the resulting two groups compared 
using a two-tailed Mann-Whitney U tests. Results from the plasma analysis of serum corticosterone and 
amphetamine levels were analysed using a two-tailed, unpaired t-test. Data from the affective bias test 
were recorded as the % negative bias, which was calculated from the number of choices made for the 
substrate paired during restrained dosing versus the number of choices made for the substrate paired 
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during the modified method. The resulting data were analysed using a one sample t-test against the 
theoretical mean of 0% choice bias, equivalent to no preference for either substrate.
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